Yeah, that seems to be the issue doesn't it. And this in a pharma sub-field infamous for not getting enough investment in corporate research because the effect

Yeah, that seems to be the issue doesn't it. And this in a pharma sub-field infamous for not getting enough investment in corporate research because the effect of novel substances is almost instantly destroyed by precisely the sort of misuse the article points to. One's tempted to dismiss any attempts to adequately explain the exploitation with either greed or stupidity as impossible, and just chalk it up to pure malice...